Rhumbline Advisers Fortress Biotech, Inc. Transaction History

Rhumbline Advisers

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.8 - $1.5 $55,281 - $103,653	-69,102 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.24 - $2.75 $10,895 - $24,164	8,787 Added 14.57%	69,102 $94,000
Q4 2021 Feb 10, 2022	SELL	$2.42 - $3.65 $723 - $1,091	-299 Reduced 0.49%	60,315 $151,000
Q3 2021 Nov 12, 2021	BUY	$2.82 - $3.7 $6,923 - $9,083	2,455 Added 4.22%	60,614 $195,000
Q2 2021 Aug 05, 2021	BUY	$3.5 - $5.48 $16,513 - $25,854	4,718 Added 8.83%	58,159 $208,000
Q1 2021 May 06, 2021	BUY	$3.16 - $4.89 $1,485 - $2,298	470 Added 0.89%	53,441 $189,000
Q4 2020 Feb 10, 2021	BUY	$2.2 - $4.45 $12,804 - $25,899	5,820 Added 12.34%	52,971 $168,000
Q3 2020 Nov 12, 2020	SELL	$2.62 - $4.78 $8,834 - $16,118	-3,372 Reduced 6.67%	47,151 $190,000
Q2 2020 Aug 13, 2020	BUY	$1.83 - $3.16 $92,457 - $159,652	50,523 New	50,523 $135,000
Q2 2019 Aug 14, 2019	SELL	$1.43 - $1.94 $63,343 - $85,934	-44,296 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$0.94 - $2.47 $784 - $2,062	-835 Reduced 1.85%	44,296 $79,000
Q4 2018 Jan 31, 2019	BUY	$0.57 - $1.53 $8,065 - $21,649	14,150 Added 45.67%	45,131 $39,000
Q3 2018 Nov 07, 2018	SELL	$1.44 - $3.13 $2,772 - $6,025	-1,925 Reduced 5.85%	30,981 $50,000
Q2 2018 Aug 06, 2018	BUY	$2.92 - $5.1 $8,628 - $15,070	2,955 Added 9.87%	32,906 $98,000
Q1 2018 May 02, 2018	SELL	$3.42 - $5.35 $1,111 - $1,738	-325 Reduced 1.07%	29,951 $136,000
Q4 2017 Feb 09, 2018	SELL	$3.26 - $4.84 $30,839 - $45,786	-9,460 Reduced 23.81%	30,276 $121,000
Q3 2017 Nov 06, 2017	BUY	$3.83 - $4.89 $152,188 - $194,309	39,736	39,736 $176,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $254M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.